Search

Your search keyword '"Shin, Dong M."' showing total 1,203 results

Search Constraints

Start Over You searched for: Author "Shin, Dong M." Remove constraint Author: "Shin, Dong M."
1,203 results on '"Shin, Dong M."'

Search Results

1. Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

2. Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

8. Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.

9. Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.

10. Prognostic biomarkers in patients with human immunodeficiency virus‐positive disease with head and neck squamous cell carcinoma

11. Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma

13. Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer

17. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial

19. Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303

20. Long‐term use of valproic acid in US veterans is associated with a reduced risk of smoking‐related cases of head and neck cancer

21. Epidemiology of Head and Neck Squamous Cell Cancer Among HIV-Infected Patients

22. Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study

23. Abstract PO-050: Preliminary results from an early-phase, open-label study of tolinapant and radiation in cisplatin-ineligible patients with previously untreated, locally advanced head and neck cancer

26. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

27. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

28. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

29. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

30. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

31. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

32. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

33. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

34. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

35. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

36. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

38. Hsp90B enhances MASTI-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation

39. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance

40. The Prometastatic Ribosomal S6 Kinase 2-cAMP Response Element-binding Protein (RSK2-CREB) Signaling Pathway Up-regulates the Actin-binding Protein Fascin-1 to Promote Tumor Metastasis*

41. p90 RSK2 Mediates Antianoikis Signals by both Transcription-Dependent and -Independent Mechanisms

42. Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies

45. Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement

49. Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.

50. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

Catalog

Books, media, physical & digital resources